Genome-scale computational methods for the identification of metabolic drug targets - application to aging and cancer
Abstract
Bio
Keren Yizhak is completing her PhD in the field of Bioinformatics at Tel Aviv University. Her research focuses on the study of human disorders in which metabolism plays a central role, such as aging, cancer, and obesity. Keren develops novel computational methods to analyze cellular metabolism, by integrating high throughput data with genome-scale metabolic models. Her goal is to advance understanding of the pathogenesis of the underlying metabolic alterations of these diseases, and suggest novel therapeutic interventions to combat them.
This talk is organized by Steve Mount